메뉴 건너뛰기




Volumn 18, Issue 4, 2014, Pages 438-440

Successes, challenges and lessons from a novel deployment of Xpert® MTB/RIF at a major South African public event

Author keywords

Community; Instrument verification; Mobile; TB

Indexed keywords

RIFAMPICIN; BACTERIAL DNA;

EID: 84897128842     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.13.0638     Document Type: Article
Times cited : (3)

References (6)
  • 1
    • 0011523808 scopus 로고    scopus 로고
    • World Health Organization. WHO/HTM/TB/2012.6. Geneva, Switzerland: WHO
    • World Health Organization. Global tuberculosis control, 2012. WHO/HTM/TB/2012.6. Geneva, Switzerland: WHO, 2012.
    • (2012) Global Tuberculosis Control, 2012
  • 4
    • 82455220460 scopus 로고    scopus 로고
    • Dried culture spots for Xpert MTB/RIF external quality assessment: Results of a phase 1 pilot study in South Africa
    • Scott L E, Gous N, Cunningham B E, et al. Dried culture spots for Xpert MTB/RIF external quality assessment: results of a phase 1 pilot study in South Africa. J Clin Microbiol 2011; 49: 4356-4360.
    • (2011) J Clin Microbiol , vol.49 , pp. 4356-4360
    • Scott, L.E.1    Gous, N.2    Cunningham, B.E.3
  • 5
    • 84865048285 scopus 로고    scopus 로고
    • Performance characteristics of the Cepheid Xpert MTB/RIF test in a tuberculosis prevalence survey
    • Dorman S E, Chihota V N, Lewis J J, et al. Performance characteristics of the Cepheid Xpert MTB/RIF test in a tuberculosis prevalence survey. PLOS ONE 2012; 7: e43307.
    • (2012) PLOS ONE , vol.7
    • Dorman, S.E.1    Chihota, V.N.2    Lewis, J.J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.